<DOC>
	<DOCNO>NCT01143168</DOCNO>
	<brief_summary>The purpose study evaluate feasibility , efficacy safety transplantation therapy use bone marrow mononuclear cell umbilical cord mesenchymal stem cell patient type 1 diabetes mellitus</brief_summary>
	<brief_title>Stem Cell Therapy Type 1 Diabetes Mellitus</brief_title>
	<detailed_description>To evaluate feasibility , safety efficacy transplantation use autologous bone marrow mononuclear cell umbilical cord mesenchymal stem cell patient type 1 diabetes mellitus .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>1 . Free take part study ability provide write informed consent . 2 . Confirmed diagnosis type I diabetes least 2 year 3 . Insulindependent . 4 . Age 1850 year , Male/Female . 5 . FBG≥7.0 mmol/L , HbAc1≥7％ . 6 . Not pregnant nursing . 7 . Negative pregnancy test . 8 . Fertile patient use effective contraception . 1 . Presence acute diabetic complication acute stage recent myocardial infarction , recent cerebral vascular accident ( CVA ) acute renal failure . 2 . Severe concurrent medical condition ( e.g . lung disease , hematopoietic dysfunction , liver dysfunction ) . 3 . Active infection require treatment . 4 . Known immunosuppressive disease , e.g . HIV infection , hepatitis B C infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>stem cell ;</keyword>
	<keyword>diabetes mellitus ;</keyword>
	<keyword>treatment .</keyword>
</DOC>